Brief: Galmed Pharmaceuticals Got Letter From Nasdaq Granted Additional 180 Calendar Day Period To Regain Compliance
19/03/2024 20:44
March 20 (Reuters) - Galmed Pharmaceuticals Ltd
GLMD.O :
* GALMED PHARMACEUTICALS - ON MARCH 19 GOT LETTER FROM
NASDAQ
THAT GRANTED CO ADDITIONAL 180 CALENDAR DAY PERIOD TO REGAIN
COMPLIANCE
Source text for Eikon: ID:n0001493152-24-010476
Further company coverage: GLMD.O
((Reuters.Briefs@thomsonreuters.com;))